Robert King

Read the latest stories and analysis from Robert King.

The study looked at whether omega-3 fatty acids, derived mainly from fish oil, can slow cognitive decline in seniors. (iStock photo)

Study doubts benefits of fish oil on brain health

Robert King · August 25, 2015 4:20 pm

In July, the FDA announced it intends to require four types of quality metrics fromÂ pharmaceuticalÂ manufacturers and three optional ones. It held a meeting to get industry feedback on the metrics on Monday.Â (AP Photo/Gregory Bull)

Government wants to grade drugmakers, but keep grades secret

Robert King · August 25, 2015 4:01 am

The lawsuit has provided House Republicans with another platform to highlight things they hate about the healthcare law and how the administration has put it in motion. (Getty Images)

Obamacare’s latest problem: Narrow doctor networks

Robert King · August 24, 2015 5:02 pm

In this Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. (AP Photo/Allen G. Breed)

OK for female sex drug follows patient-centered trend

Robert King · August 23, 2015 4:01 am

In 2009, the manufacturer of Zicam voluntarily recalled nasal products using zinc in the drug after consumers claimed they lost their ability to smell. (Getty)

Overhaul of rules for homeopathic drugs wanted

Robert King · August 21, 2015 8:44 pm

Contact lens wearers must wash hands before touching lenses and take out contacts before showering, sleeping or swimming. (Wikimedia Commons)

Nearly all contact lens wearers perform risky behaviors: CDC

Robert King · August 20, 2015 5:00 pm

Rep. Elijah E. Cummings, D-Md., asked the anti-abortion group Center for Medical Progress in a letter Thursday whether it used donations in its undercover investigation of Planned Parenthood. (Getty Images)

Democrat demands answers from group behind Planned Parenthood videos

Robert King · August 20, 2015 2:59 pm

A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals.Â Valeant Pharmaceuticals will acquire Sprout Pharmaceuticals for about $1 billion.Â (AP Photo/Allen G. Breed)

Female libido drug maker to be sold

Robert King · August 20, 2015 12:14 pm

Grumblings from insurers indicate that part of the healthcare law is collapsing. (AP Photo/David Mercer)

Study: Millions not getting Obamacare subsidies

Robert King · August 19, 2015 3:51 pm

Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi. After two rejections, the U.S. Food and Drug Administration gave approval Tuesday for the drug as a treatment for hypoactive sexual desire disorder, a first for women. (AP Photo/Allen G. Breed)

Female libido drug won’t be marketed on TV

Robert King · August 19, 2015 3:11 pm

A recent survey found that six in 10 uninsured adults cited the high costs of healthcare coverage as a reason they still don't have coverage. (AP Photo)Â

Affordability problems dog Obamacare

Robert King · August 19, 2015 4:01 am

Women with reduced sexual desire would benefit from a libido-enhancing drug, the FDA wrote, but then stressed that benefits must outweigh side effects before it will approve flibanserin. (AP Photo)Â

FDA approves female ‘Viagra’

Robert King · August 18, 2015 11:17 pm